XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.1
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities measured at fair value on a recurring basis
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2022:

(In millions)Level 1Level 2Level 3Total
Assets:
Money market funds$1,019 $— $— $1,019 
Foreign currency forward contracts
— 59 — 59 
Interest rate-related derivatives
— 10 — 10 
Total
$1,019 $69 $— $1,088 
Liabilities:
Foreign currency forward contracts
$— $47 $— $47 
Interest rate-related derivatives
— 71 — 71 
DECIEM stock options— — 74 74 
Total
$— $118 $74 $192 
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2021:

(In millions)Level 1Level 2Level 3Total
Assets:
Money market funds$2,079 $— $— $2,079 
Foreign currency forward contracts
— 52 — 52 
Interest rate-related derivatives
— 15 — 15 
Total
$2,079 $67 $— $2,146 
Liabilities:
Foreign currency forward contracts
$— $56 $— $56 
DECIEM stock options— — 141 141 
Total
$— $56 $141 $197 
Schedule of estimated fair values of financial instruments
The estimated fair values of the Company’s financial instruments are as follows:

March 31, 2022June 30, 2021
(In millions)Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Nonderivatives
Cash and cash equivalents
$3,836 $3,836 $4,958 $4,958 
Current and long-term debt
5,457 5,607 5,569 6,262 
DECIEM stock options74 74 141 141 
Derivatives
Foreign currency forward contracts – asset (liability), net12 12 (4)(4)
Interest rate-related derivatives – asset (liability), net(61)(61)15 15 
Impairment charges measured at fair value on a nonrecurring basis, classified as Level 3
The following table presents the Company’s impairment charges for the nine months ended March 31, 2022 for certain of its nonfinancial assets measured at fair value on a nonrecurring basis, classified as Level 3, due to a change in circumstances that triggered an interim impairment test:

(In millions)Impairment chargesDate of Fair Value Measurement
Fair Value(1)
Other intangible assets, net (trademarks)
GLAMGLOW$11 March 31, 2022$— 
Dr. Jart+205 February 28, 2022486 
Total216 486 
Total$216 $486 
(1)See Note 3 - Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs.

The following table presents the Company’s impairment charges for the nine months ended March 31, 2021 for certain of its nonfinancial assets measured at fair value on a nonrecurring basis, classified as Level 3, due to a change in circumstances that triggered an interim impairment test:

(In millions)Impairment chargesDate of Fair Value Measurement
Fair Value(1)
Goodwill
GLAMGLOW$54 November 30, 2020$— 
BECCA(2)
13 February 28, 2021— 
Total67 — 
Other intangible assets, net (trademark and customer lists)
GLAMGLOW27 November 30, 202036 
BECCA(2)
34 February 28, 2021— 
Total61 36 
Long-lived assets33 March 31, 202135 
Total$161 $71 
(1)See Note 3 - Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs.
(2)See Note 4 – Charges Associated with Restructuring and Other Activities for further information relating to goodwill and other intangible asset impairment charges recorded in connection with the exit of the global distribution of BECCA products.
Changes in DECEIM stock option liability
Changes in the DECIEM stock option liability for the nine months ended March 31, 2022 are included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings and were as follows:

(In millions)Fair Value
DECIEM stock option liability as of June 30, 2021$141 
Changes in fair value, net of foreign currency remeasurements(1)
(58)
Translation adjustments and other, net(9)
DECIEM stock option liability as of March 31, 2022$74 
(1)Amount includes expense attributable to graded vesting of stock options which is not material for the nine months ended March 31, 2022.